ChiCTR1800015349
尚未开始
/
/
/
2018-03-15
/
/
惡性難治腦癇症
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
非随机对照试验
治疗新技术
Non-randomized
/
N/A
/
120
/
1990-01-01
1990-01-01
/
1. Subject aged 18 years or above; 2. Subject has a diagnosis of refractory epilepsy; 3. Persistent seizures despite sequential or add-on therapy with 2 or more antiepileptic drugs 4. At least one or more non-seizure symptoms including and not limited to dizziness, vertigo, headache, insomnia, cognitive impairment and behavioural problem; 5. Subject able to speak and listen Chinese.；
请登录查看1. Abnormal renal and liver functions at baseline; 2. Concomitant antipsychotic drugs or serotonin-reuptake inhibitors; 3. Substance abuse; 4. Pregnancy or breastfeeding; 5. Active history of malignancy; 6. Unwillingness to give consent for herbal supplementation with GR by the subject or the care-taker of the subject; 7. Neurodegenerative conditions with predicted survival less than 6 months; 8. Active history of cardiovascular conditions.；
请登录查看The Chinese University of Hong Kong
/
西湖生物医药2026-02-21
Htology2026-02-21
MedTrend医趋势2026-02-21
肝脏时间2026-02-21
新通药物2026-02-21
数字医疗2026-02-21
医药笔记2026-02-21
医药笔记2026-02-21
医药笔记2026-02-21
药明康德2026-02-21
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
